Key Takeaways
- Nolla Health said on October 5, 2026 that it is the first organization in the United States to receive regulatory approval for an AI to issue initial prescriptions, and that the service is live in Utah.
- The approval lets Nolla Health's AI make the initial treatment decision and write a patient's first prescription, rather than only renewing one a clinician already ordered.
- Nolla Health raised $4.5 million and had drawn more than 55,000 users in Norway, about 1 percent of the country's population, before entering the United States.
- Utah's earlier AI prescribing pilot, launched in January 2026 with Doctronic, allowed AI to handle only prescription refills for patients with chronic conditions.
Bloomberg reported on October 5, 2026 that in a first-of-its-kind pilot, Nolla Health lets AI diagnose and issue prescriptions, and that its AI can now prescribe acne drugs in Utah. Nolla Health said it is the first organization in the United States approved for an AI to issue initial prescriptions. Luis Wenus, a Nolla Health co-founder, announced the approval.
What Nolla Health's Utah Approval Allows: AI-Issued Initial Prescriptions
Nolla Health, a health technology company, said its Utah approval covers initial prescriptions. That means its artificial intelligence can make the initial treatment decision and write a patient's first prescription, rather than only renewing a prescription a clinician has already ordered. An initial prescription is the first prescription written for a condition, so it requires a new clinical judgment rather than a repeat of an earlier one.
The company introduced the service through its dermatology product, which it markets as taking a user from a photo to a prescription. Bloomberg reported on October 5, 2026 that in a first-of-its-kind pilot, Nolla Health lets AI diagnose and issue prescriptions, and that its AI can now prescribe acne drugs in Utah.
How Nolla's AI Reads Skin: Trained on 1 Million Cases and 55,000 Patients
Nolla Health was founded by Luis Wenus, Luis Ruben Soenksen, a biomedical engineer and researcher at MIT who has built AI tools to analyze skin conditions, and Sean Geiger, a former senior software engineer at Apple. Wenus had previously helped the digital identity system World ID reach its first 2 million users. "I had really bad acne growing up, and we worked through different prescription products and ingredients and were able to solve it quickly," Wenus told Beauty Independent, describing the problem he set out to solve for others.
The company launched in Norway in November 2024 with a skin cancer screening app, followed by an acne treatment app in May 2025. Within six months it had drawn more than 55,000 patients, about 1 percent of the Norwegian population, according to Beauty Independent. Its system is trained on over 1 million cases across more than 1,600 skin conditions and, the company says, has cut clinician time per patient by a factor of 10. Nolla Health raised $4.5 million before entering the United States with its acne treatment app.
Initial Prescriptions vs Refills: How Utah's AI Prescribing Rules Expanded
Utah became the first US state to test AI prescriptions in January 2026, in a pilot with the health-tech startup Doctronic that used AI to prescribe refills for patients with chronic conditions, Semafor reported. Nolla Health's approval, by contrast, covers initial prescriptions.
The difference is the reason the announcement matters. Renewing a known prescription repeats a clinical decision a provider made earlier, while issuing an initial prescription makes that decision for the first time. Nolla Health's claim, if it holds, moves Utah's AI prescribing rules from repeat care into first-time diagnosis and treatment for the conditions its product covers.
People Also Ask
What did Nolla Health announce?
Nolla Health said on October 5, 2026 that it is the first organization in the United States approved for an AI to issue initial prescriptions, with the service live in Utah. Co-founder Luis Wenus made the announcement.
What is the difference between an initial prescription and a refill?
An initial prescription is the first prescription for a condition and requires a new treatment decision. A refill renews an existing prescription. Nolla Health's Utah approval covers initial prescriptions, while Utah's earlier Doctronic pilot covered only refills.
Who founded Nolla Health?
Nolla Health was founded by Luis Wenus, MIT biomedical engineer Luis Ruben Soenksen, and former Apple engineer Sean Geiger. Wenus previously helped the digital identity system World ID reach its first 2 million users.
How large is Nolla Health?
Nolla Health raised $4.5 million and drew more than 55,000 users in Norway, about 1 percent of the population, within six months. Its AI was trained on over 1 million cases across more than 1,600 skin conditions.
Sources: Beauty Independent, Bloomberg, Semafor.